Hyperprolactinemia during application of second-generation antipsychotics: the principles of prevention, diagnosis and correction
The article presents compelling evidence of the need to draw attention of physicians to the problem of neyroleptical hyperprolactinemia. The article provides information about different prolactogen activity of antipsychotics with the release of the safest drugs - aripiprazole and ziprasidone. Substa...
Saved in:
| Main Authors: | L. N. Gorobets, G. E. Mazo |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Federal State Budget Scientific Institution National Medical Research Center for Psychiatry and Neurology n.a. V.M. Bekhterev Ministry of Health of the Russian Federation
2018-07-01
|
| Series: | Обозрение психиатрии и медицинской психологии имени В.М. Бехтерева |
| Subjects: | |
| Online Access: | https://www.bekhterevreview.com/jour/article/view/65 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Neuroleptic hyperprolactinemia medicamentous correction
by: L. N. Gorobets, et al.
Published: (2018-07-01) -
Methods of correction of hyperprolactinemia induced by antipsychotics: current state of the problem and development prospects
by: G. E. Mazo, et al.
Published: (2024-06-01) -
Sexual differences in the clinical features of antipsychotic-induced hyperprolactinemia in patients with schizophrenia
by: E. G. Kornetova, et al.
Published: (2019-10-01) -
Risk management of metabolic disorders in the use of antipsychotics
by: G. E. Mazo, et al.
Published: (2018-07-01) -
New approaches to pharmacogenetics of drug-induced hyperprolactinemia in patients with schizophrenia
by: S. A. Ivanova
Published: (2019-12-01)